Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
      Biotech

      Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

      July 4, 2025
      Novogene Europe Expands Sequencing Capabilities with Fifth NovaSeq X Plus System in Europe
      Biotech

      Novogene Europe Expands Sequencing Capabilities with Fifth NovaSeq X Plus System in Europe

      July 3, 2025
      MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform
      Biotech

      MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

      July 3, 2025
      NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight
      Biotech

      NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

      July 2, 2025
      Invitation: Sobi’s Q2 report
      Biotech

      Invitation: Sobi’s Q2 report

      July 2, 2025
      Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma
      Biotech

      Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma

      July 1, 2025
      WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing
      Biotech

      WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing

      July 1, 2025
      Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
      Biotech

      Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

      June 30, 2025
      ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment
      Biotech

      ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment

      June 29, 2025
      Debut Named to TIME’s List of the TIME100 Most Influential Companies 2025
      Biotech

      Debut Named to TIME’s List of the TIME100 Most Influential Companies 2025

      June 28, 2025
      « 1 … 15 16 17 18 19 … 134 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026